CONNEQT Health Limited (ASX:CQT)

Market Cap	11.07M -33.6%
Revenue (ttm)	7.90M +30.5%
Net Income	-10.86M
EPS	-0.02
Shares Out	922.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,088,201
Open	0.0150
Previous Close	0.0150
Day's Range	0.0120 - 0.0150
52-Week Range	0.0120 - 0.0640
Beta	0.51
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About CONNEQT Health

CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disord...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CQT

Financial Performance

In fiscal year 2026, CONNEQT Health's revenue was 7.90 million, an increase of 30.46% compared to the previous year's 6.05 million. Losses were -10.86 million, -40.32% less than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 7, 2026

Data Sources Report a data error